GORDON CARL L 4
4 · Compass Therapeutics, Inc. · Filed Feb 13, 2025
Insider Transaction Report
Form 4
GORDON CARL L
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-11+40,000→ 40,000 totalExercise: $3.65Exp: 2035-02-11→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The options vest over 48 substantially equal monthly installments starting March 11, 2025.
- [F2]The Reporting Person is a member of OrbiMed Advisors LLC ("OrbiMed Advisors"). Pursuant to an agreement with OrbiMed Advisors, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors and OrbiMed Capital GP V LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments V-KA, LP.